Skip to content
DarshanTalks Podcast cover art

All episodes

DarshanTalks Podcast, 357 episodes. Page 3 of 4.

#
Title
201

Prep for Selling Your Company!

202

Top Tips for Starting a Clinical Trial Site

203

When Drug Reps Visit: Darshan Reacts

204

Is Pfizer competing with your pharmacy?

205

Talking to a Functional Medicine Doctor

206

Four Types of Research related Grant Fraud

207

Leveraging AI and RWD to Reshape Drug Trials!

208

DCTs in Oncology: Can They Work?

209

Marketing Due Diligence in Stem cell M&A Transactions

210

Why Are PBMs Blocking Your Meds? - Darshan reacts

211

Misleading Ads: Ad laws and Consumer Protection for Marketers

212

5 Common Clinical Trial Site Failures

213

Faster FDA Recalls

214

IRB Challenges and Updates for 2024

215

Is the Polio Vaccine Safe?

216

FDA blue print to discuss off label topics

217

Opportunities AI provides in Clinical Research

218

Telehealth and Biohacking: A Risky Combination

219

Is the FDA’s Response to AI Falling Behind?

220

Healthcare Is in Crisis: How do we fix it?

221

Will RFK Break Pharma?

222

Fake data in Clinical Trials

223

Darshan Fixes Big Pharma Misconceptions

224

How Trump’s Tariffs will Disrupt Clinical Trials and Drug Marketing?

225

Why China is Targeting Top Scientists!

226

Trump’s Bold Picks Shake Up Life Sciences

227

3 Regulatory Opportunities in Clinical Trials!

228

Don't Take Non-Prescription Ozempic or other Weight Loss Drugs

229

Clinical Trial Principal Investigator Duties in Clinical Trials

230

Supreme Court Redefined Pharma Marketing Rules

231

AI concerns in M&A for Life Sciences

232

Trump Teams Potential Changes to Healthcare

233

Can AI Rewrite the Rules of Clinical Trials?

234

Ad Promo Review in Pharma - How Far is Too Far?

235

Why Staff Training Problems are a liability for Your Clinical Trial site

236

Neuralink: Breakthrough or Marketing Hype?

237

Telehealth Compliance Crisis: DOJ exposes $2.75B Fraud!

238

Should You Go In-House or Outsource Your Advertising Compliance?

239

Research fraud tainting pharma per Nature Article

240

Influencers are NOT KOLs. Know your Needs!

241

AI and Clinical Trials: Faster Results, Bigger Risks?

242

Eli Lilly’s Unexpected Shift on Use of Mounjaro!

243

Are CROs Losing Relevance in the Age of DCTs?

244

Managing Risks in Life Science Mergers and Acquisitions with Strategic Insurance

245

Can a Pharmacist Override Your Doctor's Prescription?

246

FDA Concerns About AI’s impact on Good Clinical Practices

247

Patient Advocates Could Cost You Millions

248

Managing Risks in Life Sciences Mergers and Acquisitions

249

How do pharmacists’ read doctors’ cursive letters?

250

AI Data Ownership in Pharma

251

Role of Tech Transfer in Clinical trial agreements

252

Why are medicine names so complicated?

253

Fixing Congruency Reviews in 8 Minutes

254

The Dark Side of Med Device Kickbacks

255

Which Hair Loss Treatment Is Right for You?

256

Analyzing the Publication Rights Clause in CTAs

257

What Really Starts Pharmacy Investigations?

258

Is your clinical trial AI racist?

259

Another Pharmacy owner Jailed in Fraud Case

260

Navigating FDA's clinical trial expectations after approval

261

Legal Minute: Do dietary supplements interact with drugs?

262

How Expert Pharma Marketers Navigate Privacy

263

Hiring New Employees in PharmaTech Companies

264

3 Hidden Dangers of Telehealth Marketing

265

Why a food lawyer would stop your restaurant’s marketing?

266

Legal Minute: Why are there chemo drug shortages?

267

Are Pharma Giants Ignoring Clinical Trial Site Issues?

268

Why Adverse Events Go Unreported in Clinical Trials

269

Who are patient advocates?

270

Why Drug Accountability Matters in Clinical Trials

271

Legal Minute: What do I do if my med is on shortage?

272

5 reasons not to use AI in creating pharma marketing content

273

8 essential elements of a valid prescription

274

No more lawyers in PRC?

275

Legal Minute: 4 Ways to Get Unapproved Drugs Legally!

276

The 4 Building Blocks of Using AI in any Pharma Marketing Strategy

277

Legal Minute: Why Clinical Trials Are Right for You!

278

Why Clinical Researchers Are Flocking to MedSpas

279

Legal Minute: Why You Should Never Trust a Celebrity with Your Health

280

Essential tips for pharmacy shutdowns

281

Why Clinical Researchers Are Flocking to MedSpas

282

Legal Minute: 5 Surprising Benefits of Ozempic!

283

Who Owns AI Generated Content in Pharma?

284

Legal Minute: Why does my drug cost so much?

285

AI for Promotions in FDA-Regulated Industries

286

Legal Minute: Billion-Dollar Speaker Scheme!

287

Off-Label Risks: Compliance Matters Now More Than Ever

288

6 Must-Knows Before Buying a Drug or Device Company

289

Legal Minute: Are there chemo drug shortages?

290

Legal Minute: Don’t Ignore State Registrations

291

Legal Minute: 6 Crucial Mistakes in Informed Consent

292

Legal Minute: What is informed consent in clinical trials?

293

Stop Risky Ads: Class Actions Could Cost You

294

Legal Minute: How do drugs work?

295

5 Surprising Causes of Life Science Deal Failures

296

Legal Minute: Is pharma bribing your doctor?

297

Legal Minute: Drug Registrations that can’t be ignored

298

Legal Minute: Why do pharmacies take so long to fill prescriptions?

299

Legal Minute: 3 Steps to Avoid Food Recalls

300

Legal Minute: Are dietary supplements as good as drugs?